scholarly article | Q13442814 |
P356 | DOI | 10.2337/DIAB.25.2.116 |
P953 | full work available at URL | https://journals.org/diabetes/diabetes/article-pdf/25/2/116/336344/25-2-116.pdf |
https://diabetesjournals.org/diabetes/article-pdf/25/2/116/336344/25-2-116.pdf | ||
P698 | PubMed publication ID | 1248672 |
P2093 | author name string | N. Altszuler | |
J. Hampshire | |||
B. Gottlieb | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glucagon | Q28163629 |
internal medicine | Q11180 | ||
P304 | page(s) | 116-121 | |
P577 | publication date | 1976-02-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog | |
Interaction of Somatostatin, Glucagon, and Insulin on Hepatic Glucose Output in the Normal Dog | |||
P478 | volume | 25 |
Q40169495 | CNS Regulation of Glucagon Secretion |
Q72585522 | Catecholamine responses and their interactions with other glucoregulatory hormones |
Q72480816 | Combined effects of cold and somatostatin on glucose kinetics in dogs |
Q37031782 | Effect of glucagon on glucose production during insulin deficiency in the dog |
Q46879131 | Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis |
Q51645797 | Effect of somatostatin-induced insulinopenia on glucose oxidation in man. |
Q34575386 | Effects of alpha and beta adrenergic blockade on hepatic glucose balance before and after oral glucose. Role of insulin and glucagon |
Q41475221 | Effects of selective insulin or glucagon deficiency on glucose turnover |
Q40529785 | Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. |
Q67261042 | Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs |
Q37599189 | Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin |
Q41435995 | Influence of somatostatin on glucagon- and epinephrine-stimulated hepatic glucose output in the dog |
Q35905698 | Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans |
Q41533303 | Inhibition of glucagon-induced hepatic glucose production by indomethacin |
Q69914045 | Metabolic intervention in surgical patients. An assessment of the effect of somatostatin, ranitidine, naloxone, diclophenac, dipyridamole, or salbutamol infusion on energy and protein kinetics in surgical patients using stable and radioisotopes |
Q68950015 | Role of counterregulatory hormones in the regulation of hepatic glucose metabolism |
Q72422145 | Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis |
Q39721576 | Somatostatin: Physiology and Clinical Applications |
Q72529346 | State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes |
Q40218113 | The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity |
Q35905321 | The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog |